Ketamine Study Suggests the Psychedelic Could Treat Parkinson’s Disease
PharmaTher evaluates safety, tolerability and efficacy of low-dose ketamine infusion for treatment of LID in Parkinson’s Disease patients.
Day: March 23, 2022
End of content
End of content